Skip to main content
Top
Published in: Diabetologia 11/2017

Open Access 01-11-2017 | Article

Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor

Authors: Abigail C. Lay, Jenny A. Hurcombe, Virginie M. S. Betin, Fern Barrington, Ruth Rollason, Lan Ni, Lawrence Gillam, Grace M. E. Pearson, Mette V. Østergaard, Hellyeh Hamidi, Rachel Lennon, Gavin I. Welsh, Richard J. M. Coward

Published in: Diabetologia | Issue 11/2017

Login to get access

Abstract

Aims/hypothesis

Podocytes are insulin-responsive cells of the glomerular filtration barrier and are key in preventing albuminuria, a hallmark feature of diabetic nephropathy. While there is evidence that a loss of insulin signalling to podocytes is detrimental, the molecular mechanisms underpinning the development of podocyte insulin resistance in diabetes remain unclear. Thus, we aimed to further investigate podocyte insulin responses early in the context of diabetic nephropathy.

Methods

Conditionally immortalised human and mouse podocyte cell lines and glomeruli isolated from db/db DBA/2J mice were studied. Podocyte insulin responses were investigated with western blotting, cellular glucose uptake assays and automated fluorescent imaging of the actin cytoskeleton. Quantitative (q)RT-PCR was employed to investigate changes in mRNA. Human cell lines stably overproducing the insulin receptor (IR) and nephrin were also generated, using lentiviral constructs.

Results

Podocytes exposed to a diabetic environment (high glucose, high insulin and the proinflammatory cytokines TNF-α and IL-6) become insulin resistant with respect to glucose uptake and activation of phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signalling. These podocytes lose expression of the IR as a direct consequence of prolonged exposure to high insulin concentrations, which causes an increase in IR protein degradation via a proteasome-dependent and bafilomycin-sensitive pathway. Reintroducing the IR into insulin-resistant human podocytes rescues upstream phosphorylation events, but not glucose uptake. Stable expression of nephrin is also required for the insulin-stimulated glucose uptake response in podocytes and for efficient insulin-stimulated remodelling of the actin cytoskeleton.

Conclusions/interpretation

Together, these results suggest that IR degradation, caused by high levels of insulin, drives early podocyte insulin resistance, and that both the IR and nephrin are required for full insulin sensitivity of this cell. This could be highly relevant for the development of nephropathy in individuals with type 2 diabetes, who are commonly hyperinsulinaemic in the early phases of their disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360CrossRefPubMed Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356–360CrossRefPubMed
2.
3.
go back to reference Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed
4.
go back to reference Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE (2002) Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh epidemiology of diabetes complication study. Kidney Int 62:963–970CrossRefPubMed Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE (2002) Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh epidemiology of diabetes complication study. Kidney Int 62:963–970CrossRefPubMed
5.
go back to reference Bjornstad P, Snell-Bergeon JK, Rewers M et al (2013) Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care 36:3678–3683CrossRefPubMedPubMedCentral Bjornstad P, Snell-Bergeon JK, Rewers M et al (2013) Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care 36:3678–3683CrossRefPubMedPubMedCentral
6.
go back to reference Parvanova AI, Trevisan R, Iliev IP et al (2006) Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 55:1456–1462CrossRefPubMed Parvanova AI, Trevisan R, Iliev IP et al (2006) Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 55:1456–1462CrossRefPubMed
7.
go back to reference Pilz S, Rutters F, Nijpels G et al (2014) Insulin sensitivity and albuminuria: the RISC study. Diabetes Care 37:1597–1603CrossRefPubMed Pilz S, Rutters F, Nijpels G et al (2014) Insulin sensitivity and albuminuria: the RISC study. Diabetes Care 37:1597–1603CrossRefPubMed
8.
go back to reference Musso C, Javor E, Cochran E, Balow JE, Gorden P (2006) Spectrum of renal diseases associated with extreme forms of insulin resistance. Clin J Am Soc Nephrol: CJASN 1:616–622CrossRefPubMed Musso C, Javor E, Cochran E, Balow JE, Gorden P (2006) Spectrum of renal diseases associated with extreme forms of insulin resistance. Clin J Am Soc Nephrol: CJASN 1:616–622CrossRefPubMed
9.
go back to reference Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846CrossRefPubMed Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846CrossRefPubMed
10.
go back to reference Konner AC, Bruning JC (2012) Selective insulin and leptin resistance in metabolic disorders. Cell Metab 16:144–152CrossRefPubMed Konner AC, Bruning JC (2012) Selective insulin and leptin resistance in metabolic disorders. Cell Metab 16:144–152CrossRefPubMed
11.
go back to reference Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626–1634CrossRefPubMed Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626–1634CrossRefPubMed
12.
go back to reference Reddy GR, Kotlyarevska K, Ransom RF, Menon RK (2008) The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens 17:32–36CrossRefPubMed Reddy GR, Kotlyarevska K, Ransom RF, Menon RK (2008) The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr Opin Nephrol Hypertens 17:32–36CrossRefPubMed
13.
14.
go back to reference Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M (2007) Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 56:2155–2160CrossRefPubMed Toyoda M, Najafian B, Kim Y, Caramori ML, Mauer M (2007) Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 56:2155–2160CrossRefPubMed
15.
go back to reference Coward RJ, Welsh GI, Yang J et al (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54:3095–3102CrossRefPubMed Coward RJ, Welsh GI, Yang J et al (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54:3095–3102CrossRefPubMed
16.
17.
go back to reference Madhusudhan T, Wang H, Dong W et al (2015) Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nat Commun 6:6496CrossRefPubMedPubMedCentral Madhusudhan T, Wang H, Dong W et al (2015) Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nat Commun 6:6496CrossRefPubMedPubMedCentral
18.
go back to reference Lay A, Coward RJ (2014) Recent advances in our understanding of insulin signalling to the podocyte. Nephrol Dial Transplant 29:1127–1133 Lay A, Coward RJ (2014) Recent advances in our understanding of insulin signalling to the podocyte. Nephrol Dial Transplant 29:1127–1133
19.
go back to reference Lizotte F, Denhez B, Guay A, Gevry N, Cote AM, Geraldes P (2016) Persistent insulin resistance in podocytes caused by epigenetic changes of SHP-1 in diabetes. Diabetes 65:3705–3717CrossRefPubMed Lizotte F, Denhez B, Guay A, Gevry N, Cote AM, Geraldes P (2016) Persistent insulin resistance in podocytes caused by epigenetic changes of SHP-1 in diabetes. Diabetes 65:3705–3717CrossRefPubMed
20.
go back to reference Tejada T, Catanuto P, Ijaz A et al (2008) Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney Int 73:1385–1393CrossRefPubMed Tejada T, Catanuto P, Ijaz A et al (2008) Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney Int 73:1385–1393CrossRefPubMed
21.
go back to reference Ostergaard MV, Pinto V, Stevenson K, Worm J, Fink LN, Coward RJ (2016) DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlates with systemic insulin resistance. Am J Physiol Ren Physiol 312:F312–F321CrossRef Ostergaard MV, Pinto V, Stevenson K, Worm J, Fink LN, Coward RJ (2016) DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlates with systemic insulin resistance. Am J Physiol Ren Physiol 312:F312–F321CrossRef
22.
go back to reference Keir LS, Firth R, May C, Ni L, Welsh GI, Saleem MA (2015) Generating conditionally immortalised podocyte cell lines from wild-type mice. Nephron 129:128–136CrossRefPubMed Keir LS, Firth R, May C, Ni L, Welsh GI, Saleem MA (2015) Generating conditionally immortalised podocyte cell lines from wild-type mice. Nephron 129:128–136CrossRefPubMed
23.
go back to reference Ni L, Saleem M, Mathieson PW et al (2012) Nephrology (Carlton, Vic) 17:525–531CrossRef Ni L, Saleem M, Mathieson PW et al (2012) Nephrology (Carlton, Vic) 17:525–531CrossRef
24.
go back to reference Saleem MA, O'Hare MJ, Reiser J et al (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630–638 Saleem MA, O'Hare MJ, Reiser J et al (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630–638
25.
go back to reference Gonzalez M, Boer U, Dickel C et al (2008) Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure. Diabetologia 51:2012–2021CrossRefPubMed Gonzalez M, Boer U, Dickel C et al (2008) Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure. Diabetologia 51:2012–2021CrossRefPubMed
26.
go back to reference Garvey WT, Olefsky JM, Marshall S (1986) Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes 35:258–267CrossRefPubMed Garvey WT, Olefsky JM, Marshall S (1986) Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes 35:258–267CrossRefPubMed
27.
go back to reference Okabayashi Y, Maddux BA, McDonald AR, Logsdon CD, Williams JA, Goldfine ID (1989) Mechanisms of insulin-induced insulin-receptor downregulation. Decrease of receptor biosynthesis and mRNA levels. Diabetes 38:182–187CrossRefPubMed Okabayashi Y, Maddux BA, McDonald AR, Logsdon CD, Williams JA, Goldfine ID (1989) Mechanisms of insulin-induced insulin-receptor downregulation. Decrease of receptor biosynthesis and mRNA levels. Diabetes 38:182–187CrossRefPubMed
28.
go back to reference Gavin JR 3rd, Roth J, Neville DM Jr, de Meyts P, Buell DN (1974) Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A 71:84–88CrossRefPubMedPubMedCentral Gavin JR 3rd, Roth J, Neville DM Jr, de Meyts P, Buell DN (1974) Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A 71:84–88CrossRefPubMedPubMedCentral
29.
go back to reference Mayer CM, Belsham DD (2010) Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation. Endocrinology 151:75–84CrossRefPubMed Mayer CM, Belsham DD (2010) Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation. Endocrinology 151:75–84CrossRefPubMed
30.
go back to reference Kim B, McLean LL, Philip SS, Feldman EL (2011) Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. Endocrinology 152:3638–3647CrossRefPubMedPubMedCentral Kim B, McLean LL, Philip SS, Feldman EL (2011) Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. Endocrinology 152:3638–3647CrossRefPubMedPubMedCentral
31.
go back to reference Rollason R, Wherlock M, Heath JA, Heesom KJ, Saleem MA, Welsh GI (2016) Disease causing mutations in inverted formin 2 regulate its binding to G-actin, F-actin capping protein (CapZ alpha-1) and profilin 2. Biosci Rep 36:e00302CrossRefPubMedPubMedCentral Rollason R, Wherlock M, Heath JA, Heesom KJ, Saleem MA, Welsh GI (2016) Disease causing mutations in inverted formin 2 regulate its binding to G-actin, F-actin capping protein (CapZ alpha-1) and profilin 2. Biosci Rep 36:e00302CrossRefPubMedPubMedCentral
32.
go back to reference Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R (2009) Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30:586–623CrossRefPubMed Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R (2009) Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30:586–623CrossRefPubMed
33.
go back to reference Sbraccia P, D'Adamo M, Leonetti F et al (1996) Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma. Diabetologia 39:220–225CrossRefPubMed Sbraccia P, D'Adamo M, Leonetti F et al (1996) Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma. Diabetologia 39:220–225CrossRefPubMed
34.
go back to reference Villarreal R, Mitrofanova A, Maiguel D et al (2016) Nephrin contributes to insulin secretion and affects mammalian target of rapamycin signaling independently of insulin receptor. J Am Soc Nephrol: JASN 27:1029–1041CrossRefPubMed Villarreal R, Mitrofanova A, Maiguel D et al (2016) Nephrin contributes to insulin secretion and affects mammalian target of rapamycin signaling independently of insulin receptor. J Am Soc Nephrol: JASN 27:1029–1041CrossRefPubMed
35.
go back to reference Rowzee AM, Ludwig DL, Wood TL (2009) Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells. Endocrinology 150:3611–3619CrossRefPubMedPubMedCentral Rowzee AM, Ludwig DL, Wood TL (2009) Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells. Endocrinology 150:3611–3619CrossRefPubMedPubMedCentral
36.
37.
go back to reference Haar EV, Lee S-I, Bandhakavi S, Griffin TJ, Kim D-H (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9:316–323CrossRef Haar EV, Lee S-I, Bandhakavi S, Griffin TJ, Kim D-H (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9:316–323CrossRef
39.
go back to reference Coward RJ, Welsh GI, Koziell A et al (2007) Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 56:1127–1135CrossRefPubMed Coward RJ, Welsh GI, Koziell A et al (2007) Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 56:1127–1135CrossRefPubMed
40.
go back to reference Lennon R, Welsh GI, Singh A et al (2009) Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1. Diabetologia 52:1944–1952CrossRefPubMed Lennon R, Welsh GI, Singh A et al (2009) Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1. Diabetologia 52:1944–1952CrossRefPubMed
41.
go back to reference Morito N, Yoh K, Ojima M et al (2014) Overexpression of Mafb in podocytes protects against diabetic nephropathy. J Am Soc Nephrol 25:2546–2557 Morito N, Yoh K, Ojima M et al (2014) Overexpression of Mafb in podocytes protects against diabetic nephropathy. J Am Soc Nephrol 25:2546–2557
42.
go back to reference Na J, Sweetwyne Mariya T, Park Ae Seo D, Susztak K, Cagan Ross L (2015) Diet-induced podocyte dysfunction in drosophila and mammals. Cell Rep 12:636–647CrossRefPubMedPubMedCentral Na J, Sweetwyne Mariya T, Park Ae Seo D, Susztak K, Cagan Ross L (2015) Diet-induced podocyte dysfunction in drosophila and mammals. Cell Rep 12:636–647CrossRefPubMedPubMedCentral
43.
go back to reference Doublier S, Salvidio G, Lupia E et al (2003) Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52:1023–1030CrossRefPubMed Doublier S, Salvidio G, Lupia E et al (2003) Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52:1023–1030CrossRefPubMed
44.
go back to reference Jones N, Blasutig IM, Eremina V et al (2006) Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 440:818–823CrossRefPubMed Jones N, Blasutig IM, Eremina V et al (2006) Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 440:818–823CrossRefPubMed
46.
go back to reference Tojkander S, Gateva G, Lappalainen P (2012) Actin stress fibers—assembly, dynamics and biological roles. J Cell Sci 125(Pt 8):1855–1864CrossRefPubMed Tojkander S, Gateva G, Lappalainen P (2012) Actin stress fibers—assembly, dynamics and biological roles. J Cell Sci 125(Pt 8):1855–1864CrossRefPubMed
47.
go back to reference Shanik MH, Xu YP, Skrha J, Dankner R, Zick Y, Roth J (2008) Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31:S262–S2S8CrossRefPubMed Shanik MH, Xu YP, Skrha J, Dankner R, Zick Y, Roth J (2008) Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31:S262–S2S8CrossRefPubMed
48.
go back to reference Catalano C, Muscelli E, Quinones Galvan A et al (1997) Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes 46:868–875CrossRefPubMed Catalano C, Muscelli E, Quinones Galvan A et al (1997) Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes 46:868–875CrossRefPubMed
49.
go back to reference Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501CrossRefPubMed Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501CrossRefPubMed
50.
go back to reference Pirola L, Johnston AM, Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47:170–184CrossRefPubMed Pirola L, Johnston AM, Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47:170–184CrossRefPubMed
51.
go back to reference Hale LJ, Welsh GI, Perks CM et al (2013) Insulin-like growth factor-II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse. J Pathol 230:95–106CrossRefPubMed Hale LJ, Welsh GI, Perks CM et al (2013) Insulin-like growth factor-II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse. J Pathol 230:95–106CrossRefPubMed
52.
go back to reference Rui L, Fisher TL, Thomas J, White MF (2001) Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J Biol Chem 276:40362–40367CrossRefPubMed Rui L, Fisher TL, Thomas J, White MF (2001) Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J Biol Chem 276:40362–40367CrossRefPubMed
53.
go back to reference Mima A, Ohshiro Y, Kitada M et al (2011) Glomerular-specific protein kinase C-beta-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int 79:883–896CrossRefPubMedPubMedCentral Mima A, Ohshiro Y, Kitada M et al (2011) Glomerular-specific protein kinase C-beta-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int 79:883–896CrossRefPubMedPubMedCentral
54.
go back to reference Santamaria B, Marquez E, Lay A et al (1853) IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. Biochim Biophys Acta 2015:3224–3234 Santamaria B, Marquez E, Lay A et al (1853) IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. Biochim Biophys Acta 2015:3224–3234
55.
go back to reference Canaud G, Bienaime F, Viau A et al (2013) AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med 19:1288–1296CrossRefPubMed Canaud G, Bienaime F, Viau A et al (2013) AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat Med 19:1288–1296CrossRefPubMed
56.
go back to reference Hale LJ, Hurcombe J, Lay A et al (2013) Insulin directly stimulates VEGF-A production in the glomerular podocyte. Am J Physiol Ren Physiol 305:F182–F188CrossRef Hale LJ, Hurcombe J, Lay A et al (2013) Insulin directly stimulates VEGF-A production in the glomerular podocyte. Am J Physiol Ren Physiol 305:F182–F188CrossRef
57.
go back to reference Audzeyenka I, Rogacka D, Piwkowska A et al (2016) Reactive oxygen species are involved in insulin-dependent regulation of autophagy in primary rat podocytes. Int J Biochem Cell Biol 75:23–33CrossRefPubMed Audzeyenka I, Rogacka D, Piwkowska A et al (2016) Reactive oxygen species are involved in insulin-dependent regulation of autophagy in primary rat podocytes. Int J Biochem Cell Biol 75:23–33CrossRefPubMed
58.
go back to reference Ising C, Koehler S, Brahler S et al (2015) Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. EMBO Mol Med 7:275–287CrossRefPubMedPubMedCentral Ising C, Koehler S, Brahler S et al (2015) Inhibition of insulin/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure. EMBO Mol Med 7:275–287CrossRefPubMedPubMedCentral
Metadata
Title
Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor
Authors
Abigail C. Lay
Jenny A. Hurcombe
Virginie M. S. Betin
Fern Barrington
Ruth Rollason
Lan Ni
Lawrence Gillam
Grace M. E. Pearson
Mette V. Østergaard
Hellyeh Hamidi
Rachel Lennon
Gavin I. Welsh
Richard J. M. Coward
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4394-0

Other articles of this Issue 11/2017

Diabetologia 11/2017 Go to the issue

Up front

Up front

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.